Discover 3,592 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,592
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
for
Bipolar-I Disorder With Mania or Mania With Mixed Features
Location: Anaheim CA, Long Beach CA, Bellflower CA, Montclair CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06951698
Phase 3, Recruiting
Active & Responsive
52-week Open Label Safety-Tolerability Study
for
Schizophrenia
Location: Anaheim CA, Culver City CA, San Diego CA, Las Vegas NV,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07369154
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Fountain Valley CA, Orange CA, Long Beach CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
for
IO-resistant sqNSCLC
Location: Fountain Valley CA, Los Alamitos CA, Torrance CA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07217301
Phase 3, Recruiting
Active & Responsive
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Orange CA, Los Angeles CA, Palo Alto CA, Murray UT,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase 2, Phase 3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Orange CA, Long Beach CA, Torrance CA,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Irvine CA, Los Angeles CA, La Jolla CA, Phoenix AZ,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06578195
Recruiting
Active & Responsive
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for
Heart Failure With Preserved Ejection Fraction,
Location: Orange CA, Newport Beach CA, Covina CA, Pomona CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037459
Phase 3, Recruiting
Active & Responsive
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
for
Breast Cancer Screening, Breast Carcinoma in Situ,
Location: Irvine CA, Los Angeles CA, San Diego CA,
Sponsor: University of California, San Francisco
Sex: Female
Age: 30 - 70+
Code: NCT02620852
Recruiting
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: Orange CA, Los Angeles CA, Mission Hills CA,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase 2, Recruiting
Active & Responsive
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Irvine CA, Fullerton CA, Fontana CA, Beverly Hills CA,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT07570862
Phase 2, Recruiting
Active & Responsive
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Huntington Beach CA, Santa Barbara CA, Sacramento CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07441642
Phase 2, Recruiting
Active & Responsive
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder